The field of spinal muscular atrophy (SMA) treatment has been dynamically evolving, and the latest breakthrough stems from Scholar Rock's Phase 3 clinical trial of apitegromab. This experimental drug is designed to preserve muscle function, representing a potential new standard of care for SMA
In the rapidly evolving field of biopharmaceutical manufacturing, innovations in mycoplasma and sterility testing are becoming paramount for ensuring product safety and efficacy. Applied Biosystems™ MycoSEQ™ Plus system and the Applied Biosystems™ SteriSEQ™ Rapid Sterility Testing System, both
The controversy surrounding Cassava Sciences and its experimental Alzheimer's drug, simufilam, has garnered significant attention within the medical and research communities, as well as among regulatory bodies and patient advocacy groups. Allegations of data manipulation and scientific misconduct
Biopharmaceutical companies face numerous challenges in the quest to develop and commercialize effective oncology drugs. The intricate journey from Phase 1 trials to market approval often sees only a small fraction of drugs succeeding, and even when they do, understanding how new drug approvals
Legend Biotech is poised to enhance its cell therapy research and development capabilities with the establishment of a new R&D site in Philadelphia's Center City district. Scheduled to open by the third quarter of 2025, the 31,000-square-foot facility will employ around 55 full-time workers and be
Patient recruitment for clinical trials in the biopharma industry is often a challenging task. Successful recruitment strategies can significantly impact the efficiency and effectiveness of clinical trials, ultimately contributing to bringing new therapies to market faster. To achieve this,
